Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITOXANTRONE for Secondary progressive multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where MITOXANTRONE was used for Secondary progressive multiple sclerosis.

Most Reported Side Effects for MITOXANTRONE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 668 16.0% 87 403
Off label use 368 8.8% 82 142
Neutropenia 296 7.1% 76 144
Drug ineffective 293 7.0% 79 119
Thrombocytopenia 256 6.1% 66 128
Sepsis 240 5.8% 94 98
Pyrexia 214 5.1% 46 125
Product use in unapproved indication 177 4.3% 53 58
Disease progression 173 4.2% 58 42
Acute myeloid leukaemia 167 4.0% 78 43
Pneumonia 157 3.8% 76 71
Infection 153 3.7% 72 37
Pancytopenia 148 3.6% 24 57
Myelodysplastic syndrome 139 3.3% 35 25
Septic shock 133 3.2% 57 98

Other Indications for MITOXANTRONE

Acute myeloid leukaemia (1,248) Acute lymphocytic leukaemia (414) Diffuse large b-cell lymphoma (201) Product used for unknown indication (183) Acute promyelocytic leukaemia (158) B-cell lymphoma (125) Multiple sclerosis (112) Non-hodgkin's lymphoma (104) B-cell type acute leukaemia (101) Acute lymphocytic leukaemia recurrent (89)

Other Drugs Used for Secondary progressive multiple sclerosis

SIPONIMOD (2,265) OCRELIZUMAB (1,273) OFATUMUMAB (1,099) FINGOLIMOD (351) INTERFERON BETA-1B (146) RITUXIMAB (131) NATALIZUMAB (115) DIMETHYL (96) INTERFERON BETA-1A (89) RABEPRAZOLE (86)

Related Pages

MITOXANTRONE Full Profile All Secondary progressive multiple sclerosis Drugs MITOXANTRONE Demographics MITOXANTRONE Timeline